Meet Sol Rivera

I didn't start in a lab. I came to peptide science through skin — specifically, through wanting to understand why certain compounds worked at the cellular level when so many others didn't. Over the past decade, I've immersed myself in the published research on peptide signaling, skin regeneration, GH axis physiology, and metabolic pathways. Not as a casual reader — as someone who pulls the full-text studies, follows the citation trails, and tracks which research groups are producing work worth paying attention to.

What drew me specifically to peptides was the mechanism. I became genuinely fascinated — not in a marketing-copy way, but in a I-stayed-at-my-desk-until-2am way — by how small amino acid sequences could interact with receptor systems so precisely. The selectivity is remarkable. When you look at how something like BPC-157 modulates the nitric oxide pathway, or how a GHRH analogue can nudge pulsatile GH release without crashing the feedback loop, you start to understand why serious researchers find this class of compounds worth studying. The biology is elegant. And the research literature, while still maturing, is substantive enough to take seriously.

The problem I kept running into was translation. There were excellent papers — and then there were influencers and supplement companies making sweeping claims those papers simply did not support. The people genuinely curious about this science — the ones reading abstracts at midnight, trying to figure out what the evidence actually showed — had almost nowhere to go for honest, grounded information. The researchers weren't writing for the public, and the public-facing content wasn't written by anyone who had read the research. That gap felt like something I could help close.

I built SoliraLife to be the resource I wished had existed. Not a storefront with science-flavored marketing copy attached. Not a forum of anecdotes. An actual attempt to communicate what the research shows, how strong that evidence is, and where the honest uncertainties lie. If I do my job well, you leave this site better equipped to ask your own questions — and appropriately skeptical of anyone who promises more than the data supports.